Abstract: Angiogenesis is involved in tumor growth and metastasis. Endostatin inhibits angiogenesis, but its precise mechanism is not fully understood. To clarify signal transduction involved in endostatin-induced angiogenesis inhibition (endothelial cell growth inhibition), it is important to identify an endostatin receptor, which is the aim of the present study. We hypothesized that vascular endothelial cadherin (VE-cadherin) is an endostatin receptor and found that endostatin induced apoptosis in cultured calf pulmonary artery endothelium (CPAE) cells. Immunoprecipitation and western blots revealed that endostatin specifically bound to VE-cadherin in a Ca 2+ -dependent manner. Binding of endostatin to VE-cadherin induced tyrosine phosphorylation of VE-cadherin, β-catenin recruitment, and endothelial cell death. Antisense oligonucleotides against VE-cadherin rescued endostatin-induced endothelial cell death. Inhibition of tyrosine phosphorylation of VE-cadherin inhibited endostatin-induced β-catenin recruitment and CPAE cell death. Taken together, we conclude that VE-cadherin is an endostatin receptor.
Introduction
Angiogenesis is the recruitment of new blood vessels that occurs during wound healing, embryo development, cell growth, and tumor progression (Eatock et al. 2000; Mitchell et al. 2010; Oklu et al. 2010) . Tumors produce various angiogenesis stimulators, such as vascular endothelial growth factor (VEGF), and generate angiogenesis inhibitors, such as endostatin. Recombinant murine endostatin inhibits endothelial cell proliferation in vivo, and suppresses the metastatic growth of Lewis lung cancer cells (O'Reilly et al. 1997) . Endostatin induces apoptosis of cultured cells, and its effect is specific for endothelial cells (Dhanabal et al. 1999; Dixelius et al. 2000) . The antiangiogenic signaling network of endostatin is complex (Abdollahi et al. 2004; Benezra et al. 2004; Clamp et al. 2005) ; therefore, it is important to identify the endostatin receptors to clarify the antiangiogenic signaling network. Potential endostatin binding proteins or receptors, such as glypican, tropomyosin, nucleolin, matrix metalloproteinase, VEGFR-2, and integrin have been reported (Sasaki et al. 1999; Kim et al. 2000; Karumanchi et al. 2001; Nicholas et al. 2001; Rehn et al. 2001; Shi et al. 2007 ; Karamouzis et al. 2009 ). However, none of these proteins were found to be specific to endothelial cells. The present study aimed to identify a functional and endothelial-specific endostatin binding protein (receptor) .
Vascular endothelial (VE)-cadherin is only found at junctions of endothelial cell adherens where it interacts with β-catenin via its cytoplasmic domain (Navarro et al. 1995) . Binding of VE-cadherin to β-catenin decreases the cytoplasmic pool of free β-catenin. Monoclonal antibodies against the extracellular domain of VE-cadherin inhibit angiogenesis, cell permeability, tumor growth, and metastasis, and induce endothelial cell apoptosis (Liao et al. 2000; Corada et al. 2001) . The assembly of vascular structures in VEcadherin-null mouse embryos is severely impaired, and endothelial cells undergo apoptosis and lose the ability to respond to protective signals induced by VEGF (Carmeliet et al. 1999) . On the basis of these observations, we postulated that VE-cadherin is an endostatin binding protein, and that endostatin induces endothelial cell death via VE-cadherin.
Material and methods

Materials
Calf pulmonary artery endothelium (CPAE), MCF-7, and MDA-MB-231 cells were obtained from the Health Science Research Resource Bank (Osaka, Japan). The cells were cultured in DME medium containing 10% fetal bovine serum, 100 units/mL penicillin, 0.1 mg/mL streptomycin, and 0.25 722 T. Nemoto & S. Kubota mg/mL amphotericin B at 37
• C in a humidified 5% CO2 atmosphere. Mouse recombinant endostatin was obtained from Calbiochem (La Jolla, CA). Protein A Sepharose CL-4B beads were obtained from Sigma Chemical, Co. (St. Louis, MO). An antibody against endostatin was generated against the specific human endostatin sequence, IFS-DGKDVLRHPTWPQKSV (Nemoto et al. 2002) . The polyclonal antibody against endostatin detects type XVIII collagen, NC1 (non-collagenous-1), and endostatins of human, monkey, bovine, and mouse origin. Antibodies against VEcadherin, β-catenin, and phosphotyrosine were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies against E-cadherin and P-cadherin were obtained from Transduction Laboratories (Lexington, KY). Goat horseradish peroxidase-conjugated secondary antibodies were obtained from Funakoshi, Inc. (Tokyo, Japan).
Immunoprecipitation and western blotting Cells were washed with chilled phosphate-buffered saline (PBS) and disrupted with lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 100 mM NaF, 2 mM Na-orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 20 µg/mL aprotinin, and 20 µM leupeptin) for 20 min on ice. Cell lysates were obtained by centrifugation at 12,000×g at 4
• C for 10 min. For immunoprecipitation, protein A CL-4B Sepharose beads were incubated with bovine serum albumin (1 mg/mL) overnight and washed with PBS. A 20-µL volume of swollen protein A CL-4B beads was incubated with antibodies against endostatin (1 µg/mL), VEcadherin (1 µg/mL), and phosphotyrosine (1 µg/mL) at 4
• C for 1 h, and then mixed with the cell lysates (150 µg protein) at 4
• C for 8 h. After 3 rinsing with washing buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 100 mM NaF, 2 mM Na-orthovanadate, and 1 mM phenylmethylsulfonyl fluoride), beads were boiled in Laemmli sample buffer for 5 min. Proteins were separated by electrophoresis on 7.5% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and probed with specific antibodies. The membranes were washed three times with PBS and incubated with goat horseradish peroxidase-conjugated secondary antibodies for 1 h. After the membranes were washed three times with PBS, they were visualized by electrochemiluminescence (Amersham). Quantification of the bands was performed with NIH image Version 1.62 (Wayne Rasband, National Institutes of Health, USA).
Oligonucleotide transfection
Phosphorothioated antisense oligonucleotides against VEcadherin were synthesized by the Espec Oligo Service, Co. (Tsukuba, Japan). The sequences of antisense and scrambled oligonucleotides targeting the translation initiation codon were 5'-GAGCCTCTGCATCTT-3' and 5'-TTCTACGTCTCCGAG-3', respectively (Gene Bank Acc. No. X79981, nucleotides 22-36, containing start codon). The specificity of each oligonucleotide sequence was confirmed with the BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast. cgi). Oligonucleotides were transfected into CPAE cells with the TransFast lipofection reagent (Promega) according to the manufacturer's instructions. Cells (5×10 6 ) were incubated with the TransFast reagent with or without 10 µM oligonucleotides for 1 h, after which complete medium was added and the cells were incubated for 48 h. After two washes with PBS, the cells were incubated in serum-free medium for 6 h. Endostatin was then added, and the transfectants were harvested at 48 h. VE-cadherin expression was analyzed by western blotting. Quantitation and statistical analysis NIH image or Chemi Doc XRS (Bio-Rad) was used for analysis of the data. Results are expressed as means ± SD of three independent experiments. Significance was determined by ANOVA and Fisher's PSLD test. A P-value of less than 0.05 was considered to be significant.
Results
Endostatin induces endothelial cell apoptosis
We initially examined whether endostatin induces the death of cultured CPAE cells. A time-course analysis of CPAE cell viability revealed that 0.3 and 1 µg/mL endostatin significantly induced CPAE cell death. The viability of cells induced by 1 µg/mL endostatin was 75.0 ± 8.9% (P < 0.005), 40.2 ± 6.0% (P < 0.001), and 29.7 ± 15.4% (P < 0.001) at 24, 36, and 48 h, respectively, compared to that of each control at 24 h (94.5±2.5%), 36 h (94.8±3.7%), and 48 h (91.5 ± 5.5%). The effect of 0.3 µg/mL endostatin on cell death was less than that of 1 µg/mL endostatin. We extracted DNA from cells exposed to endostatin (1 µg/mL) to determine whether endostatin induced apoptosis. Fragmented DNA started to appear at 24 h and was obvious at 36 h and 48 h (Fig. 1A) . The effect of 0.3 µg/mL endostatin on DNA fragmentation was less prominent, compared to that of 1 µg/mL endostatin (Fig. 1B) . These findings indicated that endostatin induced apoptosis in CPAE cells.
Endostatin binds to VE-cadherin
We used immunoprecipitation and western blotting to analyze whether endostatin binds to VE-cadherin. Cells were cultured in serum-free medium for 6 h, Fig. 2 . Endostatin binds VE-cadherin. CPAE cells (5×10 6 cells/dish) were incubated with 1 µg/mL endostatin for 0, 5, and 15 min. Cell lysates (150 µg protein) were immunoprecipitated with antibody against endostatin for 8 h at 4 • C, separated by 7.5% SDS-PAGE, transferred onto nitrocellulose membranes, and then probed with antibodies against VE-cadherin (VE-CDH) (A) and P-cadherin (P-CDH) (B). After probing with HRP-conjugated secondary antibody, bands were visualized with an electrochemiluminescence system as described in Materials and methods. (C) CPAE cells were incubated with 5 mM EDTA for 15 min, then with 1 µg/mL endostatin with or without 7 mM CaCl 2 for 15 min. Cell lysates (150 µg protein) were immunoprecipitated with antibody against endostatin and detected with antibody against VE-cadherin (VE-CDH). Similar results from two independent experiments were obtained. A typical result is presented. In Figs (A) and (C), visualized bands were quantitated as described in Materials and methods, and relative levels of VE-CAD are shown as VE-CAD/IgG (H) (heavy chain of immunoglobulin G), compared to those of the control (set at 100). (D) CPAE cells were transfected with vehicle alone (TF, Transfast), VE-cadherin antisense (AS), and scrambled (Scr) oligonucleotides for 48 h; and cell lysates (100 µg protein) were separated. Similar results were obtained from two independent experiments. A typical result is shown. Relative expression levels of VE-CAD are shown, compared to that of the control set at 100. Actin levels were not significantly changed. (E) CPAE cells (5×10 5 cells/dish) were transfected with vehicle alone (TF, Transfast), VE-cadherin antisense (AS), and scrambled (Scr) oligonucleotides, incubated with 1 µg/mL endostatin for 30 h, and cell viability was determined by the trypan blue exclusion method. Open column: without endostatin; closed column: with endostatin.
and then 1 µg/mL endostatin was added for various periods. Cells were disrupted with lysis buffer containing 1% NP-40, immunoprecipitated with antibody against endostatin and western blotted against anti-VE-cadherin antibody. After incubation with endostatin, VE-cadherin was co-precipitated; and the amount of precipitated VE-cadherin significantly increased at 5 min (131.3 ± 8.9, P < 0.01) (expressed as VE-CAD/IgG) and 15 min (156.8 ± 18.2, P < 0.0005) ( Fig. 2A) , respectively, compared to the control. We also analyzed the expression levels of other cadherins. Only P-cadherin was expressed in CPAE cells; therefore, we examined whether endostatin binds to Pcadherin. As shown in Figure 2B , P-cadherin was not co-precipitated with endostatin. These results indicated that endostatin specifically binds to VE-cadherin. Because cadherins are Ca 2+ -dependent transmembrane proteins, we examined whether endostatin binding to VE-cadherin was dependent on Ca 2+ . Cells were incubated with 5 mM EDTA for 15 min, then with 1 µg/mL endostatin for 15 min. The binding of endostatin to VE-cadherin decreased to 57.7 ± 9.7 (expressed as VE-CAD/IgG) in the presence of 5 mM EDTA (P < 0.001), compared to that to the control (100 ± 6.5). Addition of 7 mM CaCl 2 restored the binding of endostatin to VE-cadherin in the presence of EDTA to the level of the control (98.5 ± 8.7, P = 0.8343 versus control; P < 0.005 versus EDTA) (Fig. 2C) . We then examined the effect of 48 h of transfection with antisense oligonucleotides against VE-cadherin. The relative expression level of VE-cadherin in antisense oligonucleotidetransfected cells (45.0 ± 4.8) was significantly lower than that of the control (100 ± 8.3) (P < 0.0001), vehicle alone (TransFast, TF, 112.5 ± 5.8) (P < 0.0001), and scrambled oligonucleotide (Scr) (P < 0.0001) (Fig. 2D) . We next examined whether decreased expression level of VE-cadherin rescued cell death induced by endostatin. Thirty hours of incubation with 1 µg/mL endostatin in serum-free medium decreased CPAE cell viability to 55.2 ± 5.4%. In contrast, serum-free medium alone induced CPAE cell death (75.1 ± 0.2%) (Fig. 2E , control) (P < 0.05, versus endostatin). Antisense oligonucleotides against VE-cadherin rescued cell viability (72.2 ± 6.9%), compared with that of the control (P < 0.05), TF (55.1 ± 6.0%) (P < 0.05), and scrambled oligonucleotides (52.8 ± 5.1%) (P < 0.05) (Fig. 2E) . We also investigated whether endostatin induced the death of other cell lines, which do not express VE-cadherin. Cell viability did not significantly change when two mammary cancer cell lines (MCF-7 and MDA-MB-231) that do not express VE-cadherin, were incubated with 1 µg/mL endostatin for 48 h (data not shown). The results suggest that binding of endostatin to VE-cadherin is responsible for the observed cell death.
VE-cadherin-related signal transduction induced by endostatin
To analyze VE-cadherin-related signal transduction induced by endostatin, we examined tyrosine phosphorylation of VE-cadherin and its binding to β-catenin. CPAE cells were incubated with 1 µg/mL endostatin, lysed, immunoprecipitated with antibodies against phosphotyrosine or VE-cadherin, and then western blotted against anti-VE-cadherin (Fig. 3A) and anti-β-catenin (Fig. 3C) antibodies, respectively. The results showed that VE-cadherin tyrosine phosphorylation was induced between 3 to 10 min after addition of endostatin (Fig. 3A) , and that recruitment of β-catenin was dependent on time (Fig. 3C) . In the absence of endostatin, levels of VE-cadherin and β-catenin expression did not change between 0 and 10 min according to the western blots ( Fig. 3B and D) . The relative quantitative expression levels of phosphorylated VE-cadherin, expressed as P-VE-CDH/total VE-CDH, at 0, 3, 5, and 10 min, were 2.9 ± 0.3, 57.0 ± 3.1, 66.3 ± 4.8, and 63.9 ± 5.2, respectively. The increases in expression levels at 3, 5, and 10 min were significant, compared to the 0-min time point (P < 0.0001). The relative expression levels of recruited β-catenin, expressed as β-catenin/total β-catenin increased with time, 0.4 ± 0.3, 10.2 ± 2.0, 21.0 ± 4.5, and 44.9 ± 7.2, at 0, 3, 5, and 10 min, respectively (P < 0.05, P < 0.01, and P < 0.0001, respectively). Thus, endostatin stimulation induced tyrosine phosphorylation of VE-cadherin, leading to β-catenin recruitment and binding to VE-cadherin.
VE-cadherin phosphorylation is critical for endostatininduced cell death
Because endostatin phosphorylated VE-cadherin and induced β-catenin recruitment, we investigated whether VE-cadherin phosphorylation is critical for endostatininduced cell death. Herbimycin A (0.2, 2.0, and 20 nM) inhibited the tyrosine phosphorylation of VE- Fig. 3 . Endostatin induces tyrosine phosphorylation of VEcadherin and catenin recruitment. CPAE cells (5×10 6 cells/dish) were incubated with 1 µg/mL endostatin for 0, 3, 5, and 10 min. Cell lysates (150 µg protein) were immunoprecipitated with antibodies against phosphotyrosine (A) or VE-cadherin (C) for 8 h at 4 • C and resolved by 7.5% SDS-PAGE. Bands were probed with antibodies against VE-cadherin (A) and β-catenin (C), respectively. Expression levels of VE-cadherin (B) and β-catenin (D) were analyzed in the same lysates by western blotting. Cell lysates (100 µg protein) were separated by 7.5% SDS-PAGE. Levels of tyrosine phosphorylation of VE-cadherin and β-catenin recruitment are expressed as P-VE-CDH/total VE-CDH and β-catenin/total β-catenin and shown in Figs (A) and (C), respectively. cadherin induced by endostatin (Fig. 4A) . We next examined whether phosphorylation of VE-cadherin was involved in β-catenin recruitment induced by endostatin. Herbimycin A (0.2, 2.0, and 20 nM) inhibited recruitment of β-catenin to VE-cadherin induced by endostatin (Fig. 4B) . These results indicated that β-catenin recruitment was dependent on tyrosine phosphorylation of VE-cadherin. We further studied whether inhibition of VE-cadherin tyrosine phosphorylation rescued CPAE cell viability. Exposure to herbimycin A (0.2, 2.0, and 20 nM) for 6 h inhibited subsequent CPAE cell death induced by endostatin at 36 h. The viability of cells induced by herbimycin A (0.2, 2.0, and 20 nM) and endostatin was 78.3 ± 9.8, 73.2 ± 4.2, and 80.5 ± 9.7%, respectively, and was significant compared to that of the control (endostatin) (42.1 ± 10.1%) (P < 0.005, P < 0.005, and P < 0.005, respectively) (Fig. 4C) . Thus, endostatin induced CPAE cell death, at least partly, in 
Discussion
The present study demonstrated that endostatin binds to VE-cadherin in a Ca 2+ -dependent manner and induces CPAE cell death mediated by VE-cadherin tyrosine phosphorylation and β-catenin recruitment. Concerning endostatin-induced signal transduction, we can ask, how is VE-cadherin related to reported endostatin binding proteins, such as glypican, tropomyosin, nucleolin, matrix metalloproteinase, VEGFR-2, and integrin? One possibility is that several pathways coexist in endostatin-mediated signal transduction. Another possibility is that VE-cadherin along with other endostatin binding proteins forms a receptor complex. In the receptor complex, VE-cadherin may play a pivotal role in mediating endostatin-induced endothelial cell apoptosis. Dixelius et al. (2000) reported that endostatininduced tyrosine kinase signaling through Shb adaptor protein regulates endothelial cell apoptosis. They also suggested that β-catenin is a potential target for endostatin-induced signaling (Dixelius et al. 2003) . Although the authors did not identify the endostatin receptor as VE-cadherin, our results are essentially consistent with theirs. VE-cadherin is expressed only in endothelial cells, where it performs multiple functions (Navarro et al. 1995) . Endothelial cell apoptosis is induced when VE-cadherin is blocked through null mutations and use of monoclonal antibodies (Carmeliet et al. 1999; Liao et al. 2000; Corada et al. 2001) . Dhanabal et al. (1999) reported that endostatin-induced endothelial cell apoptosis is regulated through the downregulation of Bcl-2 expression. Sasaki et al. (2000) reported that E-cadherin expression down-regulates Bcl-2 expression altering the availability of nuclear β-catenin. These data support our notion that the VE-cadherin/β-catenin complex plays an important role in endothelial cell apoptosis and survival.
In conclusion, we discovered that endostatin binds to VE-cadherin and induces DNA fragmentation by inducing tyrosine phosphorylation of VE-cadherin and β-catenin recruitment. Taken together, we propose that VE-cadherin is a receptor for endostatin.
